# Beta Drugs Limited (BETA)
> Exchange: NSE | Sector: Pharma | ISIN: INE351Y01019

## About
Beta Drugs Limited is a Pharma company listed on NSE.
Sector: Pharma

## Returns
1Y Return: 6.04%

## Valuation
P/E: 29.4
P/B: 8.3
EPS: ₹67.9
Book Value: ₹241.55
Dividend Yield: 0%

## Profitability
ROE: 18.6%

## Access
Current tier: anonymous
More history: Register free to see 7 more years.

## Data Freshness
Quote Updated: 2026-10-07T09:29:21.000Z
Price History Updated: 2026-10-22T14:56:19.432Z
Latest Price History Date: 2026-10-12
Technicals Updated: 2026-10-22T14:56:19.432Z
Quant Updated: 2026-10-22T14:56:19.432Z
Sentiment Updated: 2026-10-22T14:56:19.432Z
Financials Status: current
Financials Updated: 2026-10-03T13:26:52.063Z
Financials Last Attempt: 2026-10-26T16:27:43.063Z
Financials Provider Tried: yahoo
Latest P&L Period: FY26
Latest Balance Sheet Period: FY26
Latest Cash Flow Period: FY26

## P&L (TTM)
Revenue: ₹410 Cr
Operating Profit: ₹83 Cr (OPM 20%)
Net Profit: ₹46 Cr
Tax: ₹15 Cr

## Annual P&L History
TTM: Rev ₹410Cr | PAT ₹46Cr | OPM 20%
FY26: Rev ₹385Cr | PAT ₹41Cr | OPM 20%
FY25: Rev ₹362Cr | PAT ₹42Cr | OPM 21%

## Balance Sheet (FY26)
Total Assets: ₹496 Cr
Total Liabilities: ₹496 Cr
Borrowings: ₹148 Cr
Cash: —

## Shareholding
Promoters: 59.1%
FIIs: 1.02%
DIIs: 6.23%
Public: 33.65%

---
Source: rupiya.io/stocks/beta
Disclaimer: For research and education only. Not investment advice.